These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22040104)

  • 1. Effects of incretins on blood pressure: a promising therapy for type 2 diabetes mellitus with hypertension.
    Wang B; Ni Y; Zhong J; Sun F
    J Diabetes; 2012 Mar; 4(1):22-9. PubMed ID: 22040104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel role for the incretins in blood pressure regulation.
    Yerram P; Whaley-Connell A
    Curr Opin Nephrol Hypertens; 2012 Sep; 21(5):463-8. PubMed ID: 22871675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin therapy may increase blood pressure levels in type 2 diabetes mellitus.
    Kanoun F; Ben Amor Z; Zouari B; Ben Khalifa F
    Diabetes Metab; 2001 Dec; 27(6):695-700. PubMed ID: 11852379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of isolated systolic hypertension in diabetes mellitus type 2.
    Os I; Gudmundsdottir H; Kjeldsen SE; Oparil S
    Diabetes Obes Metab; 2006 Jul; 8(4):381-7. PubMed ID: 16776744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In support of an early polypharmacy approach to the treatment of type 2 diabetes.
    Wright EE; Stonehouse AH; Cuddihy RM
    Diabetes Obes Metab; 2010 Nov; 12(11):929-40. PubMed ID: 20880339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.
    Estacio RO; Jeffers BW; Gifford N; Schrier RW
    Diabetes Care; 2000 Apr; 23 Suppl 2():B54-64. PubMed ID: 10860192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure changes associated with sibutramine and weight management - an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes trial (SCOUT).
    Sharma AM; Caterson ID; Coutinho W; Finer N; Van Gaal L; Maggioni AP; Torp-Pedersen C; Bacher HP; Shepherd GM; James WP;
    Diabetes Obes Metab; 2009 Mar; 11(3):239-50. PubMed ID: 18671798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Valsartan in patients with arterial hypertension and type 2 diabetes mellitus. The lapaval study].
    Rodríguez Pérez JC; Novoa Novoa J; Caballero A; Anabitarte A; Plaza C; Palop L; Rodríguez Esparragón F
    Nefrologia; 2005; 25(5):500-8. PubMed ID: 16392299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New treatment guidelines for a patient with diabetes and hypertension.
    Mogensen CE
    J Hypertens Suppl; 2003 Mar; 21(1):S25-30. PubMed ID: 12769164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of antihypertensive agents on electrocardiographic voltage: results from the Appropriate Blood Pressure Control in Diabetes (ABCD) trial.
    Havranek EP; Esler A; Estacio RO; Mehler PS; Schrier RW;
    Am Heart J; 2003 Jun; 145(6):993-8. PubMed ID: 12796754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of glucagon-like peptide-1 on endothelial function.
    Sjöholm A
    Diabetes Obes Metab; 2009 Dec; 11 Suppl 3():19-25. PubMed ID: 19878258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DPP-4 inhibitors and GLP-1 analogues: for whom? Which place for incretins in the management of type 2 diabetic patients?
    Halimi S
    Diabetes Metab; 2008 Feb; 34 Suppl 2():S91-5. PubMed ID: 18640591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nurse-led clinics for strict hypertension control are effective long term: a 7 year follow-up study.
    Woodward A; Wallymahmed M; Wilding JP; Gill GV
    Diabet Med; 2010 Aug; 27(8):933-7. PubMed ID: 20653752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin sensitivity and the effects of antihypertensive agents: implications for the treatment of hypertension in the patient with diabetes mellitus.
    Simonson DC
    Postgrad Med J; 1988; 64 Suppl 3():39-47; discussion 48-9. PubMed ID: 3074296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to treat the diabetic hypertensive individual appropriately.
    Ruilope LM; García-Robles R
    J Hypertens Suppl; 1998 Jan; 16(1):S91-3. PubMed ID: 9534105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of hypertension and diabetes: prevalence, cardiovascular risk and protection by blood pressure reduction.
    Mancia G
    Acta Diabetol; 2005 Apr; 42 Suppl 1():S17-25. PubMed ID: 15868115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone shift circadian rhythm of blood pressure from non-dipper to dipper type in type 2 diabetes mellitus.
    Anan F; Masaki T; Fukunaga N; Teshima Y; Iwao T; Kaneda K; Umeno Y; Okada K; Wakasugi K; Yonemochi H; Eshima N; Saikawa T; Yoshimatsu H
    Eur J Clin Invest; 2007 Sep; 37(9):709-14. PubMed ID: 17696960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of antihypertensive therapy in reducing vascular complications of type 2 diabetes. Findings from the DIabetic REtinopathy Candesartan Trials-Protect 2 study.
    Tillin T; Orchard T; Malm A; Fuller J; Chaturvedi N
    J Hypertens; 2011 Jul; 29(7):1457-62. PubMed ID: 21602709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes and obesity: therapeutic targeting and risk reduction - a complex interplay.
    Niswender K
    Diabetes Obes Metab; 2010 Apr; 12(4):267-87. PubMed ID: 20380648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of and tolerance to prolonged release prazosin in patients with hypertension and non-insulin dependent diabetes].
    Hanon O; Giacomino A; Troy S; Bernaud C; Girerd X; Weber S
    Ann Cardiol Angeiol (Paris); 2000 Oct; 49(7):390-6. PubMed ID: 12555491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.